|
Tatsuhiko Sato describes for SIIC the most significant aspects of his article describe para SIIC los aspectos relevantes de su artículo Vitreous Hemorrhage after Vitrectomy with IVB for PDR EARLY VITREOUS HEMORRHAGE AFTER VITRECTOMY WITH PREOPERATIVE IVB FOR PDR We compared the surgical outcomes of vitrectomy with versus without preoperative intravitreal bevacizumab (IVB) for the repair of proliferative diabetic retinopathy. The results showed the comparable visual outcomes in the both groups although the incidence of early postoperative vitreous hemorrhage was significantly higher in the cases with IVB. The article was published by El artículo fue publicado por
Principal institution where the research took place Institución principal de la investigación Osaka Rosai Hospital, Clinical Research Center for Occupational Sensory Organ Disability, Sakai, Osaka, Japan  Authors' Report Crónica del Autor
Hemorragia del Vítreo luego de la Vitrectomía con Bevacizumab Intravítreo por Retinopatía Diabética Proliferativa
Bibliographic references Hemorragia Precoz del Vítreo luego de la Vitrectomía con Bevacizumab Intravítreo por Retinopatía Diabética Proliferativa Se comparó la evolución posquirúrgica de la vitrectomía con bevacizumab intravítreo (BIV) o sin BIV para la reparación de la retinopatía diabética proliferativa. Los resultados mostraron evolución visual semejante en los dos grupos, aunque la incidencia de hemorragia posquirúrgica precoz del vítreo fue significativamente más alta en los pacientes sometidos a vitrectomía con BIV. Crónica del Autor Imprimir nota Referencias bibliográficas Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: A randomized clinical trial. Ophthalmology 116:1943-8, 2009. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114:855-9, 2007. da R Lucena D, Ribeiro JA, Costa RA, Barbosa JC, Scott IU, de Figueiredo-Pontes LL, et al. Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study). Br J Ophthalmol 93:688-91, 2009. Itakura H, Kishi S, Kotajima N, Murakami M. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. Ophthalmology 111:1880-4, 2004. Lo WR, Kim SJ, Aaberg TM Sr, Bergstrom C, Srivastava SK, Yan J, et al. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin). Retina 29:926-31, 2009. Oshima Y, Shima C, Wakabayashi T, Kusaka S, Shiraga F, Ohji M, et al. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology 116:927-38, 2009. Rizzo S, Genovesi-Ebert F, Di Bartolo E, Vento A, Miniaci S, Williams G. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR). Graefes Arch Clin Exp Ophthalmol 246:837-42, 2008. Other articles written by the author Tatsuhiko Sato Otros artículos de Tatsuhiko Sato 1. Sato T, Kusaka S, Oshima Y, Fujikado T. Analyses of cutting and aspirating properties of vitreous cutters with high-speed camera. Retina 28:749-54, 2008. 2. Sato T, Kusaka S, Hashida N, Saishin Y, Fujikado T, Tano Y. Comprehensive gene expression profile in murine oxygen-induced retinopathy. Br J Ophthalmol 93:96-103, 2009. 3. Sato T, Kusaka S, Shimojo H, Fujikado T. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology116:1599-603, 2009. 4. Sato T, Kusaka S, Shimojo H, Fujikado T. Simultaneous analyses of twenty-seven cytokines in eyes with retinopathy of prematurity. Ophthalmology 116:2165-9, 2009. 5. Sato T, Emi K, Ikeda T, Bando H, Sato S, Morita S, Oyagi T, Sawada K. Severe intraocular inflammation after intravitreal injection of bevacizumab. Ophthalmology 17:512-6, 2010. 6. Oshima Y, Wakabayashi T, Sato T, Ohji M, Tano Y. 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology 17:93-102, 2010. 7. Sato T, Shima C, Kusaka S. Vitreous levels of angiopoietin 1 and angiopoietin 2 in eyes with retinopathy of prematurity. Am J Ophthalmol 151:353-7, 2011. 8. Sato T, Wada K, Arahori H, Kuno N, Imoto K, Iwahashi-Shima C, Kusaka S. Serum concentrations of bevacizumab (avastin®) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol 153:327-33, 2012. 9. Sato T, Sawada K, Iwahashi-Shima C, Bando H, Ikeda T, Emi K. 25-gauge vitrectomy versus intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion – 1 year follow-up. Ann Acad Med Singapore 41:294-9, 2012. 10. Sato T, Emi K, Bando H, Ikeda T. Early recovery after vitrectomy with microincision vitrectomy surgery for proliferative diabetic retinopathy. Clin Ophthalmol 6:1925-30, 2012. SIIC System of Assisted Editing (SSEA) / Sistema SIIC de Edición Asistida (SSEA)
The article is strictly related to the following sections of siicsalud El artículo se relaciona estrictamente con las siguientes secciones de siicsalud
Information about the full text Acerca del trabajo completo Early Vitreous Hemorrhage After Vitrectomy With Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy Author / Autor Tatsuhiko Sato1 1 Dr, Osaka Rosai Hospital, Clinical Research Center For Occupational Sensory Organ Disability, Sakai, Japón, Chief Physician Access to the original source Middle East African Journal of Ophthalmology Article URL: / URL del artículo: http://www.meajo.org URL of Abstract page in Medline: / URL del abstract en Medline: http://www.ncbi.nlm.nih.gov/pubmed/23580852 siic DB: / siic DB: http://www.siicsalud.com/main/distriprinrel.php |
|||||||||||||||||||||||||
Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008
